Wis. gives stem cell company $1M |
|
|
|
Published
:
Mon, 14 May 2007 21:34
|
MADISON, Wis. (AP) - A Madison stem cell company developing ways to screen drugs for side effects will receive $1 million from the state to help get started, Gov. Jim Doyle said Monday.Stemina Biomarker Discovery, Inc., is trying to commercialize discoveries made by University of Wisconsin-Madison stem cell researcher Gabriela Cezar, the company's co-founder and chief scientific officer.The company is trying to build a library of biomarkers to help companies screen drugs and drug candidates for potentially toxic side effects. Biomarkers are the signals that stem cells give off when exposed to a certain drug or disease.The goal is to discover problems with drugs earlier in the drug development process, increasing their safety and saving the companies time and money by making the process more efficient.'Dr. Cezar's company has the potential to achieve incredible breakthroughs that could save lives and create jobs,' Doyle said in a statement.Cezar, considered a star researcher who joined UW-Madison in 2005 after working as a researcher for Pfizer, Inc., called the state money 'crucial for Stemina's early development.' She said it signals the state's dedication to developing the stem cell industry.'Our community can benefit from stem cell research: as a resource to identify safer drugs for patients, as a promising cell therapy for unmet medical needs and a source of job opportunities, revenue and innovation for the state,' she said.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
Print this Story
Ore. lawmakers consider stem cell bill 